(Philadelphia, PA) - Deborah A. Sesok-Pizzini, MD, has joined the Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine, as an Assistant Professor.

In 1989, Dr. Pizzini graduated from Franklin and Marshall College, with a BA in Biology. She earned her MD from Pennsylvania State University College of Medicine and is presently in the MBA program at Villanova University. She performed her residency in the Department of Pathology and Laboratory Medicine; her Patient Oriented Research Fellowship in the Department of Medicine; and her Blood Bank and Transfusion Medicine Fellowship, all at the University of Pennsylvania Health System.

Dr. Pizzini's research focuses on Human Leukocyte Antigens (HLA) as they relate to the clinical aspects of bone marrow transplantation, solid organ transplantation, and platelet alloimmunization. At the Hospital of the University of Pennsylvania, she is the Assistant Director of the Blood Bank/Transfusion Medicine Section and Director of the Stem Cell Laboratory. She helps coordinate the Blood Bank and Apheresis/Infusion Unit's participation in extra-departmental sponsored clinical trials.

She is a member of many professional organizations including the American Association of Blood Banks, College of American Pathologists and the American Society for Clinical Pathologists. Her accolades include the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Physicians and the Transfusion Medicine Fellowship Award from the American Association of Blood Banks, among others.
Dr. Pizzini is a diplomate for the American Board of Pathology in Blood Banking, Transfusion Medicine, and Clinical Pathology. She has been invited to lecture on several occasions, most recently at the Internal Medicine Review Board Course at MCP Hahnemann University on the topic, "Bleeding Disorders: Thrombophilia: Prothrombotic Disorders."

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.

Share This Page: